During January-February 2020, coronavirus disease (COVID-19) and tuberculosis were diagnosed for 3 patients in Wuhan, China. All 3 patients had COVID-19 pneumonia. One severely ill patient died after acute respiratory distress syndrome developed. Clinicians and public health officials should be aware of underlying chronic infections such as tuberculosis in COVID-19 patients.
基金：
Ministry of Science and Technology of China; National Mega Project on Major Infectious Disease Prevention [2017ZX10103005]; National Key Research and Development Program of China [2018YFE0204500]; National Science Fund for Distinguished Young Scholars [81525023]; National Science and Technology Major Project of China [2018ZX10713001-007, 2018ZX10201001-010, 2017ZX10103009-005]; Special Fund for COVID-19 Research of Wuhan University; Fund for COVID-19 Research of Taikang Insurance Group Co., Ltd; Beijing Taikang Yicai Foundation; Sanofi Pasteur; GlaxoSmithKline; Yichang HEC Changjiang Pharmaceutical Company; Shanghai Roche Pharmaceutical Company
通讯机构：[4]Wuhan Univ, State Key Lab Virol, Wuhan, Peoples R China[*1]Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan, Peoples R China
推荐引用方式(GB/T 7714)：
Yao Zhi,Chen Junbo,Wang Qianli,et al.Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January-February 2020[J].EMERGING INFECTIOUS DISEASES.2020,26(11):2754-2757.doi:10.3201/eid2611.201536.
APA：
Yao, Zhi,Chen, Junbo,Wang, Qianli,Liu, Weiyong,Zhang, Qi...&Yu, Hongjie.(2020).Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January-February 2020.EMERGING INFECTIOUS DISEASES,26,(11)
MLA：
Yao, Zhi,et al."Three Patients with COVID-19 and Pulmonary Tuberculosis, Wuhan, China, January-February 2020".EMERGING INFECTIOUS DISEASES 26..11(2020):2754-2757
医学